The Relative Strength (RS) Rating for Chemed moved up into a new percentile Wednesday, as it got a lift from 68 to 72.
When To Sell Stocks To Lock In Profits And Minimize Losses
This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks stacks up against all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 as they launch their largest runs. See if Chemed can continue to rebound and hit that benchmark.
Chemed is working on a consolidation with a 654.62 buy point. See if it can clear the breakout price in volume at least 40% higher than normal.
Top and bottom line growth moved higher in the company's most recent quarter. Earnings were up 8%, compared to 3% in the prior report. Revenue increased from 9% to 10%.
Chemed earns the No. 4 rank among its peers in the Diversified Operations industry group. Crane is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
